“Formulated specifically for women's digestive AND vaginal/urogenital health.”
The formulation genuinely backs the digestive claim and matches the urogenital use-case by including L. reuteri and L. fermentum — the strains associated with women's flora — so this is meaningfully more than a pink-label generic. Marked partial only because the urogenital benefit rests on strain-class rationale; the strongest RCT evidence in the hub is for IBS and antibiotic-associated diarrhea, not vaginal-flora endpoints.

